MediClin AG (MED)
XDUS
5.20
0.00 (0.00%)
Closed
Sep 23, 2026
Day's Range
5.205.25
52 wk Range
2.905.65
Financial Statements - MED - MediClin AG
Revenue
784.50M▲ 4.8%
Net Income
25.90M▲ 4.0%Net Margin 3.3%
EBITDA
117.55M▲ 10.5%
Free Cash Flow
51.01M▲ 42.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 784.50M | 748.80M | 730.10M | 704.70M | 673.10M | 659.90M |
| Cost of Goods | 122.50M | 125.80M | 135.50M | 81.69M | 122.10M | 112.70M |
| Gross Profit | 662M | 623M | 594.60M | 623.01M | 551M | 547.20M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 52.50M | 52.56M | 11.69M | 69.58M | 10.89M | -694.86K |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 35.19M | 32.11M | -8.68M | 9.77M | 2.44M | -10.08M |
| Income Tax | 9.29M | 7.20M | 2.03M | 58.06K | 960.96K | -1.05M |
| Net Income | 25.90M | 24.91M | -10.72M | 9.71M | 1.48M | -9.03M |
| EPS Basic | 0.54 | 0.52 | - | 0.2 | 0.03 | -0.19 |
| EPS Diluted | 0.54 | 0.52 | - | 0.2 | 0.03 | -0.19 |
| Basic Shares Outstanding | 47.50M | 47.50M | - | 47.50M | 47.50M | 47.50M |
| Diluted Shares Outstanding | 47.50M | 47.50M | - | 47.50M | 47.50M | 47.50M |
| Ebit | 57.25M | 56.10M | 15.26M | 20.40M | 11.77M | 252.67K |
| Ebitda | 117.55M | 106.40M | 101.26M | 91.80M | 85.42M | 77.65M |
| Net Income Continuous Operations | 25.90M | 24.91M | -10.72M | 9.71M | 1.48M | -9.03M |
| Minority Interests | -415.27K | -73.62K | -52.14K | -278.33K | -23.84K | 37.88K |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
